vimarsana.com

Page 26 - கேந்ய மருத்துவ ஆராய்ச்சி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

1 in 3 people in Nairobi has been infected with Covid-19, says researchers

The survey which analysed antibodies shows seroprevalence (the level of a pathogen in a population as measured in blood serum) for the virus in Nairobi stands at 35 per cent. Seroprevalence is a way of identifying the number of people in a given population who have developed antibodies to diseases such as SARS-CoV-2, herpes simplex and HIV, following an infection. Antibodies are Y-shaped proteins that bind to the body’s foreign invaders and signal the immune system to get to work. They bind like a lock-and-key to the invaders whether they are viruses, bacteria, fungi or parasites. Subscribe to Our Newsletter

Global Leaders In HIV Prevention Research, Policy And Advocacy To Be Recognized At HIVR4P // Virtual

Friday, 29 January 2021, 5:47 am Wednesday, 27 January, 2021 (Geneva, Switzerland) Researchers, advocates and policy makers advancing global efforts to end HIV/AIDS will be honoured with awards at HIVR4P // Virtual – the HIV Research for Prevention Conference, to be held 27 & 28 January and 3 & 4 February 2021. Organized by IAS – the International AIDS Society – HIVR4P is the only global scientific conference dedicated exclusively to biomedical HIV prevention research. “The awards programme at HIVR4P // Virtual recognizes outstanding HIV prevention research, compelling advocacy to curtail the epidemic, and exceptional commitments to safeguarding the human rights of people impacted by HIV,” said IAS President Adeeba Kamarulzaman of the University of Malaya. “This conference, and these

Single dose Covid-19 shot now a possibility - Standard Health

If the single-dose vaccine is found to be effective, the company will apply for an emergency use authorisation to the US Food and Drug Administration, among other regulatory bodies, for it to be made subsequently. Whereas other vaccines are also on trial across the globe, researchers in the study have revealed that the JNJ-78436735 would be easier to administer. The dose will also reach out to more people. For example, 500 doses will be administered to 500 people. Findings of the vaccine that brought about 40,000 participants were published in the New England Journal Medicine on January 13, 2021. During trial, the vaccine was found to provide an immune response that lasted at least 71 days among participants in the age brackets of 18 and 55.

Antigen testing is a game-changer in fight against deadly virus

Country Director for CHAI Mr Gerald Macharia said 2,000 rapid antigen testing kits will be donated to Nakuru County to kick start the testing. “CHAI will also support the training of 60 Medical Lab Technologists on the Covid-19 Rapid Antigen testing,” he said. Rapid antigen testing is a diagnostic test that directly detects the presence or absence of a specific protein (antigen) that causes Covid-19. The technology does not require a laboratory for the processing of results, which are processed within 15 minutes. Also, with the technology, individuals who are at a greater risk of contracting the virus can easily be identified. Nakuru Chief Officer of Public Health Samuel King’ori said the technology will boost the fight against the spread of the virus.

Integrating modern and traditional medicine: Facts and figures

Integrating modern and traditional medicine: Facts and figures Artemisinin, which is extracted from Artemisia annua or Chinese sweet wormwood, is the basis for the most effective malaria drugs the world has ever seen. Western researchers first became aware of the compound in the 1980s, though it had long been used in China to treat malaria. But it wasn t until 2004 that the WHO endorsed its use worldwide. Much of this delay was because of the skepticism about the drug, and different research groups spent years validating the claims of Chinese traditional healers. Artemisinin is proving useful against other diseases too and has been shown to have great potential in treating cancers and schistosomiasis.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.